| Name | Title | Contact Details |
|---|
MacroGenics Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Rockville, MD. To find more information about MacroGenics Inc., please visit www.macrogenics.com
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
Vicus Therapeutics is a Morristown, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medicaid is a health and long-term care coverage program that is jointly financed by states and the federal government.
Xealth enables healthcare teams to order digital content and services as easily as they do medications today.